D. Morris

发表

RTS,S/AS01E Malaria Vaccine Induces Memory and Polyfunctional T Cell Responses in a Pediatric African Phase III Trial

M. McElrath, J. Harezlak, C. Valim, 2017, Front. Immunol..

Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial

J. Kublin, D. Montefiori, N. Frahm, 2018, The lancet. HIV.

Achieving intracellular cytokine staining assay concordance on two continents to assess HIV vaccine‐induced T‐cell responses

M. McElrath, Yunda Huang, V. Voillet, 2022, Journal of leukocyte biology.

Whole‐blood cytokine secretion assay as a high‐throughput alternative for assessing the cell‐mediated immunity profile after two doses of an adjuvanted SARS‐CoV‐2 recombinant protein vaccine candidate

M. McElrath, P. Goepfert, C. Gerard, 2022, Clinical & translational immunology.

Vaccine-Induced IgG Antibodies to V1V2 Regions of Multiple HIV-1 Subtypes Correlate with Decreased Risk of HIV-1 Infection

Gary J. Nabel, Youyi Fong, Peter B. Gilbert, 2014, PloS one.

Analysis of HLA A*02 Association with Vaccine Efficacy in the RV144 HIV-1 Vaccine Trial

Raphael Gottardo, Tomer Hertz, John Sidney, 2014, Journal of Virology.

A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection

M. Proschan, T. Chun, J. Justement, 2017, Science Translational Medicine.

Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults

B. Korber, B. Haynes, D. Montefiori, 2023, The Journal of clinical investigation.

FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial.

James Y. Dai, Jerome H. Kim, H. Liao, 2014, The Journal of clinical investigation.

Analysis of V2 Antibody Responses Induced in Vaccinees in the ALVAC/AIDSVAX HIV-1 Vaccine Efficacy Trial

Allan C. deCamp, Jerome H. Kim, B. Korber, 2013, PloS one.

DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8+ T-Cell Responses by Interleukin-12 Plasmid DNA

R. Gottardo, N. Frahm, Greg Finak, 2017, Clinical and Vaccine Immunology.

Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein

Allan C. deCamp, J. Kublin, S. Omarjee, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial.

James Y. Dai, Jerome H. Kim, B. Haynes, 2014, The Journal of clinical investigation.

S / AS 01 E Malaria Vaccine Induces Memory and Polyfunctional T Cell Responses in a Pediatric African Phase III Trial

M. McElrath, J. Harezlak, S. C. Rosa, 2017 .

Vaccine-Induced IgG Antibodies to V1V2 Regions of Multiple HIV-1 Subtypes Correlate with Decreased Risk of HIV-1 Infection

Allan C. deCamp, S. Zolla-Pazner, D. Montefiori, 2014, PloS one.